课题基金 / 基金详情

CARCINOGENESIS AND DRUG DEVELOPMENT

CARCINOGENESIS AND DRUG DEVELOPMENT
致癌和药物开发
批准号:
2894342
负责人:
Stephen J. Lippard
金额:
$47.32万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-07-01 至 2001-01-31

项目摘要

项目成果

Stephen J. Lippard的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人的描述):本培训计划的目标是培养有资格在与癌症预防和治疗相关的化学科学中做出原创性研究贡献的科学家。化学系的11名教师组成了核心研究团队,围绕该计划的教育产品建立。被录取的博士前候选人首先完成课程和考试的严格选择,之后他们集中在几个可用的研究领域之一,也可用于博士后学员,为他们的博士学位。论文该项目包括致癌作用的分子基础、抗癌药物的机理研究、新抗肿瘤剂的合成以及生物膜功能的化学方法。 具体项目包括研究DNA损伤的细胞反应、铂类抗癌药物的机制、致癌过程中的DNA损伤和遗传变化、癌症病因学和异生物质代谢、抗肿瘤抗生素所用的自由基介导的DNA降解机制、设计新抗肿瘤药物的分子识别原理、异戊二烯基作为信号转导调节剂的用途、导致肿瘤状态的细胞事件的拦截,测量环境致癌物的新分析方法的开发,以及跨膜蛋白介导的信号转导的阐明。 几个合成项目包括合成抗肿瘤和促肿瘤的天然产物和类似物,制备具有抗肿瘤活性的复杂碳芳族和杂芳族化合物,在合成抗肿瘤靶分子中使用催化抗体,以及开发基于核糖核苷酸还原酶中二铁中心抑制剂的机制。除了他们的研究,研究生和博士后学生在该计划需要通过定期安排的研讨会计划和旅行到关键的科学会议的参与,以扩大他们的知识。在麻省理工学院,学员们展示他们的研究成果,听取同事的演讲,并听取麻省理工学院和大波士顿社区癌症研究人员的各种讲座。后者包括流行病学家和临床肿瘤学家以及基础科学家。 这些研讨会使受训者全面了解环境因素在癌症病因学中的作用以及化学疗法在疾病临床管理中的作用。还定期举行小组会议,讨论研究和向学生提供咨询。 在国家和国际会议上,培训赠款的成员提交论文,并参加与他们自己的项目以及其他培训赠款项目有关的工作会议。然后,他们将他们的经验与其他学员在该计划后返回麻省理工学院。在科学的正确行为和科学道德的教育是需要通过指定的阅读和参与定期安排的会议与教师在其中的案例研究提出和讨论。 除了他们在定期安排的培训补助金研讨会的互动,学生和教师在该计划有许多正式的研究合作。此外,学员与麻省理工学院其他癌症研究实验室(包括癌症研究中心、毒理学部和怀特黑德研究所)之间也有正式和非正式的合作。
英文摘要
DESCRIPTION (Applicant's Description): The objective of this Training Program is to produce scientists qualified to make original research contributions in the chemical sciences related to the prevention and treatment of cancer. Eleven faculty members of the Chemistry Department constitute the core research team around which the educational offerings of the program are built. Predoctoral candidates admitted to the program first complete a rigorous selection of courses and examinations after which they concentrate in one of several available research areas, also available to postdoctoral trainees, for their Ph.D. dissertation. Included in this offering are projects in the molecular basis of carcinogenesis, mechanistic studies of anticancer drugs, the synthesis of new antitumor agents, and chemical approaches to the function of biological membranes. Specific projects include studies of cellular responses of DNA damage, the mechanism of platinum anticancer drugs, DNA damage and genetic changes in carcinogenesis, cancer etiology and xenobiotic metabolism, mechanisms of radical-mediated DNA degradation employed by antitumor antibiotics, the principles of molecular recognition to design new antitumor drugs, use of prenyl groups as modulators of signal transduction, interception of cellular events leading to the tumor state, development of new analytical methods to measure environmental carcinogens, and elucidation of signal transduction as mediated by transmembrane proteins. Several synthetic projects include the synthesis of antitumor and tumor-promoting natural products and analogs, the preparation of complex carboaromatic and heteroaromatic compounds exhibiting antitumor activity, the use of catalytic antibodies in synthesis of antitumor target molecules, and the development of mechanism based inhibitors of the diiron center in ribonucleotide reductase. In addition to their research, graduate and postdoctoral students in the program are required to expand their knowledge through participation in a regularly scheduled seminar program and by travel to key scientific meetings. At MIT, trainees present their research results, listen to presentations by their colleagues, and hear a variety of lectures by cancer researchers in the MIT and greater Boston communities. Included in the latter group are epidemiologists and clinical oncologists as well as basic scientists. These seminars give the trainees a comprehensive picture of the roles of environmental factors in the etiology of cancer and of chemotherapy in the clinical management of the disease. Subgroup meetings to discuss research and advise students are also held regularly. At national and international meetings, members of the training grant give papers and attend sessions on work related to their own project as well as the projects of others on the training grant. They then relate their experiences to other trainees in the program upon returning to MIT. Education in the proper conduct of science and in scientific ethics is required through assigned readings and participation in regularly scheduled sessions with the faculty in which case studies are presented and discussed. Apart from their interactions at the regularly scheduled training grant seminars, students and faculty in the program have many formal research collaborations. In addition, there is both formal and informal cooperation among trainees and other MIT cancer research laborato- ries, including those in the Center of Cancer Research, the Toxicology Division, and the Whitehead Institute.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURAL STUDIES OF BACTERIAL MULTICOMPONENT MONOOXYGENASES
  • 批准号:
    8362193
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2011
  • 负责人:
    Stephen J. Lippard
  • 依托单位:
INVESTIGATIONS OF CISPLATIN-DNA CROSS-LINKS ON NUCLEOSOME CORE PARTICLES
  • 批准号:
    8169250
  • 项目类别:
  • 资助金额:
    $0.35万
  • 财政年份:
    2010
  • 负责人:
    Stephen J. Lippard
  • 依托单位:
STRUCTURAL STUDIES OF BACTERIAL MULTICOMPONENT MONOOXYGENASES
  • 批准号:
    8170154
  • 项目类别:
  • 资助金额:
    $0.13万
  • 财政年份:
    2010
  • 负责人:
    Stephen J. Lippard
  • 依托单位:
STRUCTURAL STUDIES OF MULTICOMPONENT BACTERIAL MONOOXYGENASES
  • 批准号:
    8169251
  • 项目类别:
  • 资助金额:
    $0.35万
  • 财政年份:
    2010
  • 负责人:
    Stephen J. Lippard
  • 依托单位:
国内基金
海外基金
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
  • 批准号:
    61372188
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    陈秀杰
  • 依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
  • 批准号:
    61073135
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    梅虎
  • 依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
  • 批准号:
    20776012
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2007
  • 负责人:
    张慧
  • 依托单位: